Vaxil BioTherapeutics
Vaxil BioTherapeutics is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines.
Vaxil BioTherapeutics is a company in biotechnology, health diagnostics, therapeutics based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2007.
Its activity falls under biotechnology, health diagnostics, therapeutics; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
It is recorded at the Private company stage.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Health Diagnostics, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2007 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: vxlbio.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account